Peritoneal metastasis inhibition by linoleic acid with activation of PPARγ in human gastrointestinal cancer cells

Virchows Archiv

Volumn 448, Issue 4, 2006, Pages 422-427

  Sasaki, Takamitsu ^a   Fujii, Kiyomu ^a   Yoshida, Kazuhiro ^b   Shimura, Hideo ^c   Sasahira, Tomonori ^a   Ohmori, Hitoshi ^a   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

15 Lipoxygenase 1; Gastrointestinal cancer; Linoleic acid; Peritoneal metastasis; Peroxisome proliferator activated receptor gamma

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ARACHIDONATE 15 LIPOXYGENASE; COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONATE 15-LIPOXYGENASE; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LINOLEIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PERITONEAL NEOPLASMS; PPAR GAMMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33645574930     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0110-4     Document Type: Article

References (20)

1. Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ (2004) Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor γ. Cancer Res 64:1181-1189
2. Belury MA (2002) Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132:2995-2998
3. Chang WC, Chapkin RS, Lupton JR (1997) Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18:721-730
4. Chen A, Xu J (2004) Activation of PPARγ by curcumin inhibits Moser cell growth and mediates the suppression of the gene expression of cyclinD1 and EGFR. Am J Physiol Gastrointest Liver Physiol 14:14
5. Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11-21
6. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, Hamamoto T, Tahara H, Tahara E (1997) Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Differ 8:47-52
7. Liu JJ, Huang RW, Lin DJ, Peng J, Wu XY, Lin Q, Pan XL, Song YQ, Zhang MH, Hou M, Chen F (2005) Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro. Ann Oncol 10:10
8. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Keys SD (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 16:1447-1449
9. Miller A, Stanton C, Devery R (2002) Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res 22:3879-3887
10. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93:229-240
11. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H (2003) Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124:361-367
12. Rao CV, Hirose Y, Indranie C, Reddy BS (2001) Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61:1927-1933
13. Reddy BS, Burill C, Rigotty J (1991) Effect of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 51:487-491
14. Singh J, Hamid R, Reddy BS (1997) Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57:3465-3470
15. Sugarbaker PH (2002) New responsibilities in the management of colorectal cancer with peritoneal seeding. Cancer Invest 20:1118-1122
16. Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21:233-248
17. Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y, Kudo J, Konishi S, Kato J, Koyama H, Kimura M, Sato A, Shinoda N, Kuwabara Y, Fujii Y (2002) Decreased peroxisome proliferator-activated receptor γ gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32:238-243
18. Vogel I, Kalthoff H (2001) Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 439:109-117
19. Yoshizumi T, Ohta T, Ninomiya I, Terada I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Yi S, Miwa K (2004) Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 25:631-639
20. Zhou S, Wang G, Chen B, Wang P (2000) Effect of dietary fatty acids on tumorigenesis of colon cancer induced by methyl nitrosourea in rats. J Environ Pathol Toxicol Oncol 19:81-86